Synovial fluid fingerprinting in end-stage knee osteoarthritis A NOVEL BIOMARKER CONCEPT

被引:13
作者
Jayadev, C. [1 ]
Hulley, P. [1 ]
Swales, C. [1 ]
Snelling, S. [1 ]
Collins, G. [1 ]
Taylor, P. [2 ]
Price, A. [3 ]
机构
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[2] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Musculoskeletal Sci, Oxford, England
[3] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Orthopaed Surg, Oxford, England
来源
BONE & JOINT RESEARCH | 2020年 / 9卷 / 09期
关键词
Osteoarthritis; Biomarker; Machine learning; JOINT REPLACEMENT; OUTCOME MEASURE; INJURIES; DISEASE; MRI; PLS;
D O I
10.1302/2046-3758.99.BJR-2019-0192.R1
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Aims The lack of disease-modifying treatments for osteoarthritis (OA) is linked to a shortage of suitable biomarkers. This study combines multi-molecule synovial fluid analysis with machine learning to produce an accurate diagnostic biomarker model for end-stage knee OA (esOA). Methods Synovial fluid (SF) from patients with esOA, non-OA knee injury, and inflammatory knee arthritis were analyzed for 35 potential markers using immunoassays. Partial least square discriminant analysis (PLS-DA) was used to derive a biomarker model for cohort classification. The ability of the biomarker model to diagnose esOA was validated by identical wide-spectrum SF analysis of a test cohort of ten patients with esOA. Results PLS-DA produced a streamlined biomarker model with excellent sensitivity (95%), specificity (98.4%), and reliability (97.4%). The eight-biomarker model produced a fingerprint for esOA comprising type IIA procollagen N-terminal propeptide (PIIANP), tissue inhibitor of metalloproteinase (TIMP)-1, a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4), monocyte chemoattractant protein (MCP)-1, interferon-gamma-inducible protein-10 (IP-10), and transforming growth factor (TGF)-beta 3. Receiver operating characteristic (ROC) analysis demonstrated excellent discriminatory accuracy: area under the curve (AUC) being 0.970 for esOA, 0.957 for knee injury, and 1 for inflammatory arthritis. All ten validation test patients were classified correctly as esOA (accuracy 100%; reliability 100%) by the biomarker model. Conclusion SF analysis coupled with machine learning produced a partially validated biomarker model with cohort-specific fingerprints that accurately and reliably discriminated esOA from knee injury and inflammatory arthritis with almost 100% efficacy. The presented findings and approach represent a new biomarker concept and potential diagnostic tool to stage disease in therapy trials and monitor the efficacy of such interventions.
引用
收藏
页码:623 / 632
页数:10
相关论文
共 28 条
[1]   Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis [J].
Altman, RD ;
Abadie, E ;
Avouac, B ;
Bouvenot, G ;
Branco, J ;
Bruyere, O ;
Calvo, G ;
Devogelaer, JP ;
Dreiser, RL ;
Herrero-Beaumont, G ;
Kahan, A ;
Kreutz, G ;
Laslop, A ;
Lemmel, EM ;
Menkes, CJ ;
Pavelka, K ;
Van De Putte, L ;
Vanhaelst, L ;
Reginster, JY .
OSTEOARTHRITIS AND CARTILAGE, 2005, 13 (01) :13-19
[2]   The discordance between clinical and radiographic knee osteoarthritis: A systematic search and summary of the literature [J].
Bedson, John ;
Croft, Peter R. .
BMC MUSCULOSKELETAL DISORDERS, 2008, 9 (1)
[3]   Knee replacement [J].
Carr, Andrew J. ;
Robertsson, Otto ;
Graves, Stephen ;
Price, Andrew J. ;
Arden, Nigel K. ;
Judge, Andrew ;
Beard, David J. .
LANCET, 2012, 379 (9823) :1331-1340
[4]   Synovial fluid interleukin-16, interleukin-18, and CRELD2 as novel biomarkers of prosthetic joint infections [J].
Chen, M-F ;
Chang, C-H ;
Yang, L-Y ;
Hsieh, P-H ;
Shih, H-N ;
Ueng, S. W. N. ;
Chang, Y. .
BONE & JOINT RESEARCH, 2019, 8 (04) :179-188
[5]   Biologic agents in osteoarthritis: hopes and disappointments [J].
Chevalier, Xavier ;
Eymard, Florent ;
Richette, Pascal .
NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (07) :400-410
[6]   Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group [J].
Conaghan, P. G. ;
Hunter, D. J. ;
Maillefert, J. F. ;
Reichmann, W. M. ;
Losina, E. .
OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (05) :606-610
[7]  
Eriksson L., 2013, Multi- and Megavariate Data Analysis Basic Principles and Applications, P55
[8]   CV-ANOVA for significance testing of PLS and OPLS® models [J].
Eriksson, Lennart ;
Trygg, Johan ;
Wold, Svante .
JOURNAL OF CHEMOMETRICS, 2008, 22 (11-12) :594-600
[9]   Virtual joint replacement as an outcome measure in OA [J].
Felson, David T. .
NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (04) :187-188
[10]   An Accurate Substitution Method for Analyzing Censored Data [J].
Ganser, Gary H. ;
Hewett, Paul .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE, 2010, 7 (04) :233-244